IQVIA Holdings Inc. ("IQVIA") (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has ...

In the UK, wide‑ranging reforms coming into force on 28 April 2026 are designed to streamline approvals, embed a more ...

Industry discussions focus on how oxygen-enriched HyOx water may enhance topical formulations, merging clinical ...

As a chief executive officer, scientific adviser, and champion for research, Frank L. Douglas, PhD, MD, is a notable figure in his field. For this reason, Marquis Who’s Who has honored Dr. Douglas as ...

Some processes have plagued the research industry for decades. They’re inefficient and unpopular, but somehow resistant to ...

NINGBO, ZHEJIANG PROVINCE, CHINA, January 19, 2026 /EINPresswire.com/ -- In recent years, the global healthcare ...

Conflict of interest reporting is flawed and inconsistent across clinical trials assessing the effectiveness of corticosteroid injections in knee osteoarthritis, according to data published in ...

The federal government is awarding up to $144 million in contracts to several universities and other research teams to study age-related illnesses and healthy longevity.

NDA for rusfertide submitted to the US Food and Drug Administration (FDA), with potential approval and launch this ...

The International Family Medicine Roundtable committee unveiled the official publication of its landmark strategic whitepaper ...

NEWARK, CA / ACCESS Newswire / February 25, 2026 / Protagonist Therapeutics (Nasdaq:PTGX) (“Protagonist” or “the Company”) today reported financial results for the fourth quarter and full year ended ...

Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the ...